Induced pluripotent stem cells generated without viral integration - PubMed (original) (raw)
Induced pluripotent stem cells generated without viral integration
Matthias Stadtfeld et al. Science. 2008.
Abstract
Pluripotent stem cells have been generated from mouse and human somatic cells by viral expression of the transcription factors Oct4, Sox2, Klf4, and c-Myc. A major limitation of this technology is the use of potentially harmful genome-integrating viruses. We generated mouse induced pluripotent stem (iPS) cells from fibroblasts and liver cells by using nonintegrating adenoviruses transiently expressing Oct4, Sox2, Klf4, and c-Myc. These adenoviral iPS (adeno-iPS) cells show DNA demethylation characteristic of reprogrammed cells, express endogenous pluripotency genes, form teratomas, and contribute to multiple tissues, including the germ line, in chimeric mice. Our results provide strong evidence that insertional mutagenesis is not required for in vitro reprogramming. Adenoviral reprogramming may provide an improved method for generating and studying patient-specific stem cells and for comparing embryonic stem cells and iPS cells.
Figures
Figure 1. Analysis of pluripotency markers in Adeno-iPS cells
(A) Brightfield (upper panel) and fluorescence (lower panel) images of an Adeno-iPS cell clone established from Sox2-GFP fetal liver cells taken at passage 0 (P0) and passage 2 (P2). (B) Expression of endogenous c-myc, Klf4, Oct4, Sox2 and nanog measured by qPCR in Adeno-iPS cells derived from fetal liver (FL), fibroblasts (TTF) and hepatocytes (HEP) as well as in V6.5 control ES cells. (C) Bisulfite sequencing of the Oct4 and Nanog promoters in hepatocytes, ES cells and iPS cells derived from hepatocytes. Open circles represent unmethylated CpGs; closed circles denote methylated CpGs. (D) Expression levels of endogenous gapdh (G) as well as adenoviral c-myc (M), Klf4 (K), Oct4 (O) and Sox2 (S) in fibroblasts three days after infection with adenoviruses (TTF + 4 adenos), ES cells and Adeno-iPS cells derived from fetal liver, fibroblasts and hepatocytes. Error bars indicate one standard deviation. The absence of a bar indicates that the respective cDNA was not detected.
Figure 2. Absence of viral integration in Adeno-iPS cell
(A) Schematic drawing of the adenoviral vector indicating the position of the cDNA and the sizes of the respective DNA fragments after BamHI digestion. The bracketed BamHI site is only present in the Oct4 cDNA. A pBluescript (pBS) sequence present in both the adenoviral vector and the _Oct4_IND transgene is highlighted. (B) PCR analyses for adenoviral integration in genomic DNA from the indicated Adeno-iPS clones as well as from V6.5 ES cells that served as a negative control (−). Arrowhead indicates the position of the positive control band amplified from vector DNA (+). (C) Southern blot analysis of BamHI-digested genomic DNA using DNA fragments encompassing the entire adenoviral vector backbone isolated from pAd-Oct4 as probes. Plasmid DNA of pAd-Klf4 and pAd-Oct4 diluted to the equivalent of 0.2, 1 or 2.5 integrations per genome and genomic DNA of HEK cells (which contain adenoviral sequences in their genome) were used as positive controls. An asterisk (*) indicates bands resulting from hybridization of the pBS sequence in the adenoviral probe to transgenic sequences in the _Oct4_IND allele. Note that these bands are absent in HEP iPS, V6.5 ES and HEK cells. A double asterisk (**) indicates bands resulting from hybridization of parts of the probe to sequences present in the endogenous Oct4 locus or in Oct4 pseudogenes. These bands are present in all lanes containing genomic DNA including the wild type control and therefore serve as loading controls. Solid arrowheads indicate the position of BamHI fragments of the adenoviral vector and open arrowheads highlight adenoviral sequences detected in HEK cells.
Figure 3. Pluripotency of Adeno-iPS cell
(A–C) Images of histological sections through teratomas formed by Adeno-iPS cells subjected to hematoxylin and eosin staining, showing keratinized epithelium (A), mucous epithelium (B) and cartilage (C). (D–I) Fluorescence images showing the contribution of red fluorescent protein-labeled Adeno-iPS cells to lung, brain and heart in a postnatal chimeric animal. Nuclei were counterstained with DAPI (blue). The small insets in (D, F, H) highlight the fields magnified in (E, G, I) whereas the insets in (E, G, I) show the background fluorescent levels and DAPI staining of corresponding tissues in a non-chimeric littermate. (J, K) Images of coat-color chimeras derived from fetal liver (J) and hepatocytes (K) Adeno-iPS cells. (L–O) Fluorescence and brightfield images of a wild type (L, M) blastocyst and an Oct4-GFP (N, O) blastocyst obtained after mating a chimeric mouse made with TTF-1 iPS cells expressing GFP from the Oct4 promoter with a wild type female.
Comment in
- Induced pluripotent stem cells generated without viral integration.
Eggenschwiler R, Cantz T. Eggenschwiler R, et al. Hepatology. 2009 Mar;49(3):1048-9. doi: 10.1002/hep.22827. Hepatology. 2009. PMID: 19242974 No abstract available.
Similar articles
- Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells.
Zhou W, Freed CR. Zhou W, et al. Stem Cells. 2009 Nov;27(11):2667-74. doi: 10.1002/stem.201. Stem Cells. 2009. PMID: 19697349 - Generation of mouse induced pluripotent stem cells without viral vectors.
Okita K, Nakagawa M, Hyenjong H, Ichisaka T, Yamanaka S. Okita K, et al. Science. 2008 Nov 7;322(5903):949-53. doi: 10.1126/science.1164270. Epub 2008 Oct 9. Science. 2008. PMID: 18845712 - Reprogramming adipose tissue-derived mesenchymal stem cells into pluripotent stem cells by a mutant adeno-associated viral vector.
Chen MJ, Lu Y, Hamazaki T, Tsai HY, Erger K, Conlon T, Elshikha AS, Li H, Srivastava A, Yao C, Brantly M, Chiodo V, Hauswirth W, Terada N, Song S. Chen MJ, et al. Hum Gene Ther Methods. 2014 Feb;25(1):72-82. doi: 10.1089/hgtb.2013.011. Epub 2013 Dec 28. Hum Gene Ther Methods. 2014. PMID: 24191859 Free PMC article. - Generation of clinically relevant "induced pluripotent stem" (iPS) cells.
Heffernan C, Sumer H, Verma PJ. Heffernan C, et al. J Stem Cells. 2011;6(3):109-27. J Stem Cells. 2011. PMID: 23264997 Review. - Emerging methods for preparing iPS cells.
Miyazaki S, Yamamoto H, Miyoshi N, Takahashi H, Suzuki Y, Haraguchi N, Ishii H, Doki Y, Mori M. Miyazaki S, et al. Jpn J Clin Oncol. 2012 Sep;42(9):773-9. doi: 10.1093/jjco/hys108. Epub 2012 Jul 23. Jpn J Clin Oncol. 2012. PMID: 22826352 Review.
Cited by
- Dopaminergic progenitors generated by small molecule approach survived, integrated, and promoted functional recovery in (6-OHDA) mouse model of Parkinson's disease.
Alexanian AR, Sorokin A, Duersteler M. Alexanian AR, et al. J Neurol Sci. 2024 Oct 15;465:123188. doi: 10.1016/j.jns.2024.123188. Epub 2024 Aug 20. J Neurol Sci. 2024. PMID: 39178824 - Generation of induced pluripotent stem cells from the Asian bats.
Lee Y, Koo O, Saadeldin IM. Lee Y, et al. Int J Vet Sci Med. 2024 Aug 12;12(1):81-90. doi: 10.1080/23144599.2024.2384835. eCollection 2024. Int J Vet Sci Med. 2024. PMID: 39139714 Free PMC article. - Advances in induced pluripotent stem cell-derived cardiac myocytes: technological breakthroughs, key discoveries and new applications.
Clancy CE, Santana LF. Clancy CE, et al. J Physiol. 2024 Aug;602(16):3871-3892. doi: 10.1113/JP282562. Epub 2024 Jul 20. J Physiol. 2024. PMID: 39032073 Review. - Possible Strategies to Reduce the Tumorigenic Risk of Reprogrammed Normal and Cancer Cells.
Lin YC, Ku CC, Wuputra K, Liu CJ, Wu DC, Satou M, Mitsui Y, Saito S, Yokoyama KK. Lin YC, et al. Int J Mol Sci. 2024 May 9;25(10):5177. doi: 10.3390/ijms25105177. Int J Mol Sci. 2024. PMID: 38791215 Free PMC article. Review. - Mesenchymal stem cells in craniofacial reconstruction: a comprehensive review.
Zheng Z, Liu H, Liu S, Luo E, Liu X. Zheng Z, et al. Front Mol Biosci. 2024 Apr 16;11:1362338. doi: 10.3389/fmolb.2024.1362338. eCollection 2024. Front Mol Biosci. 2024. PMID: 38690295 Free PMC article. Review.
References
- Takahashi K, Yamanaka S. Cell. 2006 Aug 25;126:663–76. - PubMed
- Eminli S, Utikal J, Arnold K, Jaenisch R, Hochedlinger K. Stem Cells. 2008 in press. - PubMed
- Maherali N, et al. Cell Stem Cell. 2008 in press. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials